CTSB and glioblastoma: Cathepsin B (Cat B), a lysosomal protease overexpressed in tumors, including glioblastoma, recognizes the valine-alanine (VA) dipeptide sequence, leading to linker cleavage and drug release in the tumor microenvironment [30,37].